Discontinuing JAK Inhibitors and Hair Loss in Severe Alopecia Areata Patients
Exploring the necessity of long-term baricitinib therapy for sustained hair regrowth in alopecia areata patients.
Topline:
Discontinuing baricitinib therapy after successful hair regrowth in severe alopecia areata patients led to significant hair loss, highlighting the need for ongoing treatment to maintain benefits.
Study Details:
Severe alopecia areata, an autoimmune condition resulting in hair loss, has seen advancements in treatment with the introduction of Janus …
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.